Drug repurposing of Nifuratel against methicillin-resistant Staphylococcus aureus through proton motive force disruption
These results identify Nifuratel as a promising repurposed antimicrobial agent against MRSA. Its dual capability to exert direct bactericidal activity by disrupting PMF and attenuate key virulence factors, combined with a favorable resistance profile and biocompatibility <i>in vivo</i>, supports its potential for further therapeutic development.
Authors
- Di Zhang
- Bingqin Qin
- Kening Lin
Institutions
- Central South University (CN)
- Chenzhou First People's Hospital (CN)
- Third Xiangya Hospital (CN)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2026-01-09
- DOI
- https://doi.org/10.3389/fcimb.2025.1738031
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Central South University
- China National Tobacco Corporation
- Xiangya Hospital, Central South University